Re: The Induction of Core Pluripotency Master Regulators in Cancers Defines Poor Clinical Outcomes and Treatment Resistance.
Atala A. Re: The Induction of Core Pluripotency Master Regulators in Cancers Defines Poor Clinical Outcomes and Treatment Resistance. J Urol. 2019 10; 202(4):663.